Cargando…
Clinical analysis of EGFR‐positive non‐small cell lung cancer patients treated with first‐line afatinib: A Nagano Lung Cancer Research Group
BACKGROUND: In the LUX‐Lung 3 and LUX‐Lung 6 trials, afatinib improved overall survival in previously untreated patients with EGFR 19del mutated non‐small cell lung cancer (NSCLC) compared to chemotherapy. The appropriate management of adverse events and dose reduction of afatinib are important for...
Autores principales: | Sonehara, Kei, Kobayashi, Takashi, Tateishi, Kazunari, Morozumi, Nobutoshi, Yoshiike, Fumiaki, Hachiya, Tsutomu, Ono, Yasushi, Takasuna, Keiichirou, Agatsuma, Toshihiko, Masubuchi, Takeshi, Matsuo, Akemi, Tanaka, Hozumi, Morikawa, Akio, Hanaoka, Masayuki, Koizumi, Tomonobu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons Australia, Ltd
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6501023/ https://www.ncbi.nlm.nih.gov/pubmed/31006178 http://dx.doi.org/10.1111/1759-7714.13047 |
Ejemplares similares
-
Rechallenge of afatinib for EGFR-mutated non-small cell lung cancer previously treated with osimertinib: a multicenter phase II trial protocol (REAL study)
por: Araki, Taisuke, et al.
Publicado: (2023) -
Predictive value of post‐treatment C‐reactive protein‐to‐albumin ratio in locally advanced non–small cell lung cancer patients receiving durvalumab after chemoradiotherapy
por: Araki, Taisuke, et al.
Publicado: (2022) -
Association of lung immune prognostic index with survival outcome in advanced thymic carcinoma patients treated with palliative intent chemotherapy
por: Araki, Taisuke, et al.
Publicado: (2022) -
The efficacy of amrubicin third‐line chemotherapy in patients with relapsed extensive‐disease small‐cell lung cancer: A retrospective and historical study in a single institute
por: Sonehara, Kei, et al.
Publicado: (2019) -
C‐PLAN index as a prognostic factor for patients with previously untreated advanced non‐small cell lung cancer who received combination immunotherapy: A multicenter retrospective study
por: Sonehara, Kei, et al.
Publicado: (2023)